NPY1R

Chr 4

neuropeptide Y receptor Y1

Also known as: NPY1-R, NPYR

The protein is a G-protein-coupled receptor that mediates the function of neuropeptide Y (NPY), a neurotransmitter, and peptide YY (PYY), a gastrointestinal hormone, activating intracellular signaling pathways including calcium mobilization and adenylate cyclase inhibition. Mutations in this gene have been associated with autosomal recessive obesity and feeding disorders in pediatric patients. The gene shows tolerance to loss-of-function variants (LOEUF 0.84), suggesting that complete loss of function may be required for disease manifestation.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
39
Pubs (1 yr)
41
P/LP submissions
0%
P/LP missense
0.84
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryNPY1R
Population Constraint (gnomAD)
Low constraint (pLI 0.04) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
41 unique Pathogenic / Likely Pathogenic· 39 VUS of 84 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.84LOEUF
pLI 0.043
Z-score 1.94
OE 0.37 (0.180.84)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.78Z-score
OE missense 0.65 (0.560.75)
132 obs / 203.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.37 (0.180.84)
00.351.4
Missense OE0.65 (0.560.75)
00.61.4
Synonymous OE1.03
01.21.6
LoF obs/exp: 4 / 10.9Missense obs/exp: 132 / 203.4Syn Z: -0.21
DN
0.82top 10%
GOF
0.85top 5%
LOF
0.2092th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

84 submitted variants in ClinVar

Classification Summary

Pathogenic39
Likely Pathogenic2
VUS39
Likely Benign1
Benign1
39
Pathogenic
2
Likely Pathogenic
39
VUS
1
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
39
0
39
Likely Pathogenic
0
0
2
0
2
VUS
0
33
6
0
39
Likely Benign
0
1
0
0
1
Benign
0
1
0
0
1
Total03547082

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NPY1R · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →